Immuneering (IMRX) Net Income (2020 - 2026)
Immuneering's Net Income was -$17.92 million in Q2 2026, compared with -$14.43 million a year earlier.
Powered by 
Analysis
Immuneering (IMRX) Net Income (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immuneering's Net Income was -$58.75 million through Jun 30, 2026; for FY2025, it came in at -$56.34 million.
- In earlier years, Net Income was -$61.48 million in FY2024, -$54.81 million in FY2023, -$50.51 million in FY2022 and -$33.54 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Net Income since Q4 2024.
- Per Business Quant data, IMRX's Net Income in the three quarters before Q2 2026 was -$13.97 million (Q1 2026), -$11.89 million (Q4 2025) and -$14.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Immuneering | 267.20 Mn | 267.20 Mn | - | -17.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.92 Mn |
| Mar 31, 2026 | -13.97 Mn |
| Dec 31, 2025 | -11.89 Mn |
| Sep 30, 2025 | -14.96 Mn |
| Jun 30, 2025 | -14.43 Mn |
| Mar 31, 2025 | -15.05 Mn |
| Dec 31, 2024 | -18.14 Mn |
| Sep 30, 2024 | -14.73 Mn |
| Jun 30, 2024 | -14.09 Mn |
| Mar 31, 2024 | -14.52 Mn |
| Dec 31, 2023 | -15.55 Mn |
| Sep 30, 2023 | -13.07 Mn |
| Jun 30, 2023 | -12.34 Mn |
| Mar 31, 2023 | -13.85 Mn |
| Dec 31, 2022 | -13.47 Mn |
| Sep 30, 2022 | -12.97 Mn |
| Jun 30, 2022 | -11.50 Mn |
| Mar 31, 2022 | -12.79 Mn |
| Dec 31, 2021 | -10.97 Mn |
| Sep 30, 2021 | -8.53 Mn |
API Access
Immuneering Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();